Agenus | AGEN - Себестоимость





Себестоимость Изменить Дата
AbbVie USD 4.22B 329M 2026-03
Agenus USD 642K 399K 2025-09
Amgen USD 1.6B 187M 2026-03
AstraZeneca USD -204M 3.48B 2026-03
Bristol-Myers Squibb USD 3.86B 1.07B 2026-03
Celldex Therapeutics USD 54.2M 8.94M 2025-06
CSL USD 3.87B 2.08B 2025-12
Eli Lilly USD 3.58B 205M 2026-03
Gilead Sciences USD 1.44B 174M 2026-03
GlaxoSmithKline GBP 1.88B 736M 2026-03
Glaxosmithkline GBP 1.88B 1.6B 2026-03
Incyte USD 104.5M 16.68M 2026-03
Intrexon USD 1.01M 344K 2024-06
J&J USD 8B 67M 2026-06
Jiangsu Hengrui CNY 1.09B 76.27M 2026-03
Karyopharm Therapeutics USD 1.48M 35.95M 2025-12
MacroGenics USD 9.53M 585K 2026-03
Merck EUR 2.07B 219M 2026-03
Merck USD 2.94B 380M 2026-03
Novartis USD 3.46B 83M 2026-03
Novavax USD 22.1M 608K 2025-12
Pfizer USD 4.59B 1.7B 2026-03
Regeneron Pharmaceuticals USD 669.4M 84.8M 2026-03
Rigel Pharmaceuticals USD 8.03M 5.22M 2024-09
Sangamo BioSciences 2.42M 1.11M 2024-06
Veracyte USD 38.49M 794K 2026-03